Page last updated: 2024-08-23

paclitaxel and pyrimidine

paclitaxel has been researched along with pyrimidine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bai, Y; Chu, YP; Gong, JF; Li, J; Li, Y; Shen, L; Zhang, XT1
Baratelli, C; Chau, I; Cunningham, D; Kalaitzaki, E; Morano, F; Rao, S; Sclafani, F; Starling, N; Watkins, D1
Biankin, AV; Chantrill, L; Chin, V; Nagrial, A; O'Connor, CA; Scholten, RJ; Sjoquist, K; Yip, D1

Reviews

1 review(s) available for paclitaxel and pyrimidine

ArticleYear
Chemotherapy and radiotherapy for advanced pancreatic cancer.
    The Cochrane database of systematic reviews, 2018, 03-20, Volume: 3

    Topics: Albumins; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Epirubicin; Fluorouracil; Gemcitabine; Humans; Paclitaxel; Pancreatic Neoplasms; Pyrimidines; Randomized Controlled Trials as Topic; Treatment Outcome

2018

Trials

1 trial(s) available for paclitaxel and pyrimidine

ArticleYear
A phase II study of triweekly paclitaxel and capecitabine combination therapy in patients with fluoropyrimidine-platinum-resistant metastatic gastric adenocarcinoma.
    Journal of cancer research and therapeutics, 2013, Volume: 9 Suppl

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Fluorouracil; Humans; Male; Middle Aged; Paclitaxel; Platinum; Pyrimidines; Stomach Neoplasms

2013

Other Studies

1 other study(ies) available for paclitaxel and pyrimidine

ArticleYear
Platinum-Fluoropyrimidine and Paclitaxel-Based Chemotherapy in the Treatment of Advanced Anal Cancer Patients.
    The oncologist, 2017, Volume: 22, Issue:4

    Topics: Adult; Aged; Anus Neoplasms; Combined Modality Therapy; Disease-Free Survival; Female; Humans; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Platinum; Prognosis; Pyrimidines

2017